Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Efficacy and Safety × Tegafur × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 4 Uterine Cervical Neoplasms 1 Pancreatic Neoplasms 1 HER2-positive Gastric Cancer 1 Efficacy and Safety 1

Interventions

irinotecan sucrosofate 1 Tegafur 1 S 1 (combination) 1 Oxaliplatin 1 Leucovorin 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06383078 2024-04-25

HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Not yet recruiting

Efficacy and Safety

Data powered by HemOnc (CC BY 4.0) Colophon ⚡